Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
The price of Shiba Inu is stabilizing, the market may be facing major turbulence

The price of Shiba Inu is stabilizing, the market may be facing major turbulence

Bitget2024/02/06 11:00
According to CryptoPotato, Shiba Inu is currently showing a stable trend, but this could be the calm before the storm. Key support level: $0.0000087, key resistance level: $0.0000095. Over the past two weeks, SHIB price has been consolidating between key levels. Currently, the support at $0.000087 is holding well and buyers may attempt to challenge the resistance at $0.0000095 in the near future.
 
Since its recent high point in December, Shiba Inu's trading volume has been declining steadily. Recently volatility has also significantly decreased with almost no significant fluctuations which might indicate that pressure is building up for a major change in future.The MACD histogram on daily time frame remains steady which was expected considering that price has been consolidating for some time now.However,the bullish crossover of MACD moving averages towards end of January is a positive signal for buyers.SHIB's bias remains neutral.In short term,a return of buying volume would be needed for SHIB prices to rise.Until then,this consolidation phase might continue.
 
 
 
 
1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)